CJC-1295 with DAC and Metformin Interaction

Synergistic
Mechanism-based 51% confidence

CJC-1295 with DAC and Metformin have a synergistic interaction with 51% confidence. CJC-1295 with DAC helps counteract the insulin-disrupting effects of Metformin. A smart combination — the insulin sensitizer mitigates metabolic side effects. These compounds primarily affect different organ systems.

Compound Profiles

CJC-1295 with DAC

Long-Acting Growth Hormone Releasing Hormone Analog | Extended Release

DAC binds to albumin, extending half-life to 6-8 days and providing continuous GHRH receptor stimulation for sustained GH/IGF-1 elevation..

Half-life: 6-8 days Typical dose: 1-2mg weekly growth hormone, weight loss
ghrh receptorigf1 carcinogenic riskestrogenicinsulin disrupting
View full profile

Metformin

Biguanide | AMPK Activator & Longevity Research

Metformin exerts its primary effects through activation of AMP-activated protein kinase (AMPK), the cell's master energy sensor. AMPK activation triggers a cascade of downstream metabolic improvements: enhanced glucose uptake in skeletal muscle, suppression of hepatic gluconeogenesis, improved mitochondrial function, and increased fatty acid oxidation.

Half-life: ~5 hours Typical dose: 500-2000 mg/day longevity, metabolic
ampkmtor gabaergicinsulin sensitizing
View full profile

Combined Organ Load

GI Tract
low
Pituitary
low
Pancreas
low

Frequently Asked Questions

Can I take CJC-1295 with DAC with Metformin?

Yes, CJC-1295 with DAC and Metformin can generally be taken together. CJC-1295 with DAC helps counteract the insulin-disrupting effects of Metformin. A smart combination — the insulin sensitizer mitigates metabolic side effects.

Is CJC-1295 with DAC and Metformin safe together?

Based on pharmacological analysis, this combination is considered synergistic. No critical safety flags identified for this pair.

What are the interactions between CJC-1295 with DAC and Metformin?

CJC-1295 with DAC helps counteract the insulin-disrupting effects of Metformin. A smart combination — the insulin sensitizer mitigates metabolic side effects. This assessment has 51% confidence and is inferred from pharmacological mechanism analysis.

How should I time CJC-1295 with DAC and Metformin?

CJC-1295 with DAC has a half-life of 6-8 days and Metformin has a half-life of ~5 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: CJC-1295 with DAC vs Metformin

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.